February 8, 2008 - The FDA granted Volcano Corp. 510(k) clearance for its s5-Revo and s5-FFR (fractional flow reserve) options, allowing physicians access phased Array IVUS, Rotational IVUS and integrated FFR on the same integrated IVUS platform. The two new products enable rotational IVUS and FFR to operate on the same integrated Volcano s5 Imaging System as Volcano’s previous line of phased array IVUS catheters and functionality. Earlier generation consoles included only one of the three technologies now available on the s5. If a hospital wanted to equip a new lab with all three technologies, they would have to acquire three separate consoles, each with a different measurement modality, training requirements and data storage protocols. The Volcano s5 can now accommodate the three primary intravascular diagnostic tools in regular use by cardiologists today (high frequency rotational IVUS, fast and simple digital IVUS and pressure-based FFR guidewires) on a single platform. The first installations of the Volcano s5-Revo and s5-FFR Options under a limited market release strategy will commence shortly with a full market release expected in the first half of 2008. The Volcano s5-Revo and s5-FFR options complement the existing s5 functionality, including ChromaFlo for stent apposition assessment, and VH(TM) IVUS plaque composition analysis. The Volcano s5 Imaging System has been tested in cooperation with GE, Philips, Siemens and Toshiba for safety and compatibility when used with their current lines of x-ray systems and equipment. The Volcano s5 has also been tested for compatibility with eleven different DICOM providers, and for Worklist compatibility with image storage in the same patient "jacket" as the angiogram.
Technology | February 07, 2008
Array, Rotational, FFR Offered on Single IVUS Platform
News | FFR Technologies | August 18, 2020
August 18, 2020 — Philips Healthcare introduced its new OmniWire, the world’s first solid core...
News | FFR Technologies | July 09, 2020
July 9, 2020 – Acist Medical Systems Inc., a Bracco Group Company, announced the global launch of its Acist Navvus II
Feature | FFR Technologies | July 07, 2020 | Dave Fornell, Editor
News | FFR Technologies | May 15, 2020
May 15, 2020 – A late-breaking study aimed to evaluate whether...
Videos | FFR Technologies | March 26, 2020
Feature | FFR Technologies | August 05, 2019 | Dave Fornell and Greg Freiherr
New technologies have been developed that may replace the traditional pressure wires and adenosine to assess the...
News | FFR Technologies | June 17, 2019
A prospective, multicenter, multinational study examines how fractional flow reserve (FFR) can impact treatment plans...
News | FFR Technologies | March 20, 2019
At the American College of Cardiology’s (ACC) annual meeting, March 16-18 in New Orleans, Philips announced the results...
News | FFR Technologies | March 19, 2019
Late-breaking results confirm the HeartFlow FFRct (fractional flow reserve computed tomography) Analysis enables...
Technology | FFR Technologies | March 06, 2019
March 5, 2019 – The U.S.